January 5, 2018 / 2:16 PM / Updated 7 minutes ago BRIEF-Diplomat Reaffirms 2017 Guidance And Provides Preliminary 2018 Outlook Reuters Staff 
Jan 5 (Reuters) - Diplomat Pharmacy Inc: 
* DIPLOMAT PHARMACY INC - ‍JEFF PARK, HAS BEEN APPOINTED INTERIM CHIEF EXECUTIVE OFFICER, EFFECTIVE IMMEDIATELY​ 
* DIPLOMAT PHARMACY INC - PHIL HAGERMAN TO CONTINUE SERVICE ON BOARD AND BECOME CHAIRMAN EMERITUS 
* DIPLOMAT PHARMACY INC - BOARD HAS APPOINTED BEN WOLIN, INDEPENDENT LEAD DIRECTOR, AS CHAIRMAN OF DIPLOMAT BOARD, EFFECTIVE IMMEDIATELY 
* DIPLOMAT INITIATES CEO TRANSITION; REAFFIRMS 2017 GUIDANCE AND PROVIDES PRELIMINARY 2018 OUTLOOK 
* DIPLOMAT PHARMACY - ‍PARK‘S APPOINTMENT FOLLOWS RETIREMENT OF PHIL HAGERMAN 
* DIPLOMAT PHARMACY INC - IN 2018, DIPLOMAT PRELIMINARILY EXPECTS REVENUE IN RANGE OF $5.3 TO $5.6 BILLION Source text for Eikon: Further company coverage: